ArticleTherapeutic advances in musculoskeletal disease2021

Factors affecting drug survival of an alternative TNF inhibitor and secukinumab in patients with ankylosing spondylitis switching from the first TNF inhibitor.

Oh Chan Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.